$4.46
-0.09-1.98%
At Close: -
$4.55
0.092.02%
After Hours: 4:10 PM EDT
15 minutes delayed
Comments
Loading...
Fate Therapeutics
FATENASDAQ
Fate Therapeutics (FATE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestFate Therapeutics (NASDAQ:FATE) Stock Quotes, Forecast and News Summary
Fate Therapeutics Stock (NASDAQ: FATE) stock price, news, charts, stock research, profile.
| Open | $4.41 |
| Close | $4.46 |
| Volume / Avg. | 3.45M / 2.44M |
| Day Range | 4.28 - 4.74 |
| 52 Wk Range | 1.63 - 8.83 |
| Market Cap | $517.94M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 73 |
| Short Interest | 20.03% |
| Days to Cover | 7.19 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Fate Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It i...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fate Therapeutics (FATE) stock?
You can purchase shares of Fate Therapeutics (NASDAQ:FATE) through any online brokerage.
Who are Fate Therapeutics (FATE) competitors?
Other companies in Fate Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and PepGen (NASDAQ:PEPG).
What is the target price for Fate Therapeutics (FATE) stock?
There is no analysis for Fate Therapeutics.
What is the forecast for Fate Therapeutics (FATE) stock?
Fate Therapeutics has a consensus price target of $10.75.
Current stock price for Fate Therapeutics (FATE)?
The stock price for Fate Therapeutics (NASDAQ: FATE) is $4.55 last updated Today at July 17, 2024 at 4:10 PM EDT.
Does Fate Therapeutics (FATE) pay a dividend?
There are no upcoming dividends for Fate Therapeutics.
When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?
Fate Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Fate Therapeutics (FATE) going to split?
There is no upcoming split for Fate Therapeutics.
What sector and industry does Fate Therapeutics (FATE) operate in?
Fate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.